Indexed keywords
HIGH YIELD;
NO CARRIER ADDED;
RADIOIODINATION;
ROOM TEMPERATURE;
IODINE;
MOLECULAR BIOLOGY;
MOLECULAR STRUCTURE;
OXIDANTS;
RADIOACTIVITY;
SOLVENTS;
DRUG PRODUCTS;
2 IODO 8 METHYL 8H QUINO[4,3,2 KL]ACRIDINE;
AMMONIUM 2 (2' PHOSPHORYLOXYPHENYL) 6 IODO 3 (3H) QUINAZOLINONE;
BOLTON HUNTER REAGENT I 125;
DIIODORHODAMINE 123;
DIMETHYL SULFOXIDE;
IDOXURIDINE;
IMMUNOGLOBULIN G;
IODINE;
IODINE 123;
MONOCLONAL ANTIBODY B72.3 I 125;
MONOIODORHODAMINE 123;
RADIOPHARMACEUTICAL AGENT;
RHODAMINE 123;
RHODAMINE 127;
TRACER;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG SYNTHESIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
ISOTOPE LABELING;
PRIORITY JOURNAL;
RADIOIODINATION;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DIMETHYL SULFOXIDE;
IMMUNOGLOBULIN G;
IODINE RADIOISOTOPES;
MICE;
RADIOCHEMISTRY;
RADIOPHARMACEUTICALS;
SOLVENTS;
1
0028236995
Radiolabeling kit/generator for 5-radiohalogenated uridines
Baranowska-Kortylewicz J., et al. Radiolabeling kit/generator for 5-radiohalogenated uridines. J. Label. Compd. Radiopharm. 34 (1994) 513-521
(1994)
J. Label. Compd. Radiopharm. , vol.34
, pp. 513-521
Baranowska-Kortylewicz, J.1
2
0015795516
125I-containing acylating agent. Application to the radioimmunoassay
125I-containing acylating agent. Application to the radioimmunoassay. Biochem. J. 133 (1973) 529-539
(1973)
Biochem. J. , vol.133
, pp. 529-539
Bolton, A.E.1
Hunter, W.M.2
3
33846226440
In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy
Chen K., et al. In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy. Mol. Cancer Ther. 5 (2006) 3001-3013
(2006)
Mol. Cancer Ther. , vol.5
, pp. 3001-3013
Chen, K.1
4
33847356832
Molecular-docking-guided design, synthesis, and biologic evaluation of radioiodinated quinazolinone prodrugs
Chen K., et al. Molecular-docking-guided design, synthesis, and biologic evaluation of radioiodinated quinazolinone prodrugs. J. Med. Chem. 50 (2007) 663-673
(2007)
J. Med. Chem. , vol.50
, pp. 663-673
Chen, K.1
5
0030119622
Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation
Foulon C.F., et al. Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation. J. Nucl. Med. 37 4, Suppl. (1996) 1S-3S
(1996)
J. Nucl. Med. , vol.37
, Issue.4 SUPPL
Foulon, C.F.1
6
0032482258
99mTc]hexakis(2-methoxyisobutylisonitrile)
99mTc]hexakis(2-methoxyisobutylisonitrile). J. Med. Chem. 41 (1998) 2111-2117
(1998)
J. Med. Chem. , vol.41
, pp. 2111-2117
Harapanhalli, R.S.1
7
0037203972
Antitumor polycyclic acridines. 8. Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts
Heald R.A., et al. Antitumor polycyclic acridines. 8. Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J. Med. Chem. 45 (2002) 590-597
(2002)
J. Med. Chem. , vol.45
, pp. 590-597
Heald, R.A.1
8
0036009653
Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy
Ho N., et al. Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy. Bioconjugate Chem. 13 (2002) 357-364
(2002)
Bioconjugate Chem. , vol.13
, pp. 357-364
Ho, N.1
9
28244470314
Radiotargeting agents for cancer therapy
Kassis A.I. Radiotargeting agents for cancer therapy. Expert Opin. Drug Deliv. 2 (2005) 981-991
(2005)
Expert Opin. Drug Deliv. , vol.2
, pp. 981-991
Kassis, A.I.1
10
0023134984
125IUdR in mammalian cells: implications of localized energy deposition by Auger processes
125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiat. Res. 109 (1987) 78-89
(1987)
Radiat. Res. , vol.109
, pp. 78-89
Kassis, A.I.1
11
0029921429
Antibody-dependent signal amplification in tumor xenografts following pretreatment with biotinylated monoclonal antibody and avidin or streptavidin
Kassis A.I., et al. Antibody-dependent signal amplification in tumor xenografts following pretreatment with biotinylated monoclonal antibody and avidin or streptavidin. J. Nucl. Med. 37 (1996) 343-352
(1996)
J. Nucl. Med. , vol.37
, pp. 343-352
Kassis, A.I.1
12
12344306166
125I]iodo-2′-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis
125I]iodo-2′-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. Int. J. Radiat. Biol. 80 (2004) 941-946
(2004)
Int. J. Radiat. Biol. , vol.80
, pp. 941-946
Kassis, A.I.1
13
0023636065
127/125I) derivatives of rhodamine 123
127/125I) derivatives of rhodamine 123. J. Med. Chem. 30 (1987) 1757-1761
(1987)
J. Med. Chem. , vol.30
, pp. 1757-1761
Kinsey, B.M.1
14
22144477893
131I]iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice
131I]iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice. Nucl. Med. Biol. 32 (2005) 647-653
(2005)
Nucl. Med. Biol. , vol.32
, pp. 647-653
Kumar, P.1
15
0025870484
Radioiodinated 1-(5-iodo-5-deoxy-β-d-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia
Mannan R.H., et al. Radioiodinated 1-(5-iodo-5-deoxy-β-d-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia. J. Nucl. Med. 32 (1991) 1764-1770
(1991)
J. Nucl. Med. , vol.32
, pp. 1764-1770
Mannan, R.H.1
16
0030449547
123I]iodo-2′-deoxyuridine in patients with liver metastases from colorectal cancer
123I]iodo-2′-deoxyuridine in patients with liver metastases from colorectal cancer. Acta Oncol. 35 (1996) 941-945
(1996)
Acta Oncol. , vol.35
, pp. 941-945
Mariani, G.1
17
0023127968
Radioiodinated rhodamine-123: a potential cationic hepatobiliary imaging agent
Moonen P., et al. Radioiodinated rhodamine-123: a potential cationic hepatobiliary imaging agent. Nucl. Med. Commun. 8 (1987) 99-104
(1987)
Nucl. Med. Commun. , vol.8
, pp. 99-104
Moonen, P.1
18
33947236862
Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors
Pospisil P., et al. Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors. Cancer Res. 67 (2007) 2197-2205
(2007)
Cancer Res. , vol.67
, pp. 2197-2205
Pospisil, P.1
19
0001607761
Synthesis and biological activities of iododeoxyuridine, an analog of thymidine
Prusoff W.H. Synthesis and biological activities of iododeoxyuridine, an analog of thymidine. Biochim. Biophys. Acta 32 (1959) 295-296
(1959)
Biochim. Biophys. Acta , vol.32
, pp. 295-296
Prusoff, W.H.1
20
0027199946
Iododeoxyuridine uptake and retention as a measure of tumor growth
Tjuvajev J., et al. Iododeoxyuridine uptake and retention as a measure of tumor growth. J. Nucl. Med. 34 (1993) 1152-1162
(1993)
J. Nucl. Med. , vol.34
, pp. 1152-1162
Tjuvajev, J.1
21
0029875321
Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer
Van den Abbeele A.D., et al. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer. J. Nucl. Med. 37 (1996) 315-320
(1996)
J. Nucl. Med. , vol.37
, pp. 315-320
Van den Abbeele, A.D.1
22
33947264285
Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative
Wang K., et al. Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative. Bioconjugate Chem. 18 (2007) 754-764
(2007)
Bioconjugate Chem. , vol.18
, pp. 754-764
Wang, K.1
